Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm Paradigm announced today that it has signed a deal under which its PCDx next-generation sequencing-based cancer test will be covered by health insurer Three Rivers Provider Network.

According to Paradigm, Three Rivers has more than 15 million US members.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.